Polar Capital Global Healthcare Trust PLC (LON:PCGH) had added a stake in UK pharma giant AstraZeneca PLC (LON:AZN) to its top ten holdings, while also increasing its share of US group Pfizer Inc (NYSE:PFE).
In a portfolio update as of 31 May, the investment manager revealed a stake in AZ accounting for 3.7% of its holdings, while its Pfizer holding has increased its share to 5.6% from 4.6% in April.
In terms of sectors, healthcare equipment was the largest segment in the portfolio at 38%, up from 33.1% the previous month, while the previous largest sector, pharmaceuticals, has been reduced to 30.6% from 36.4%.
Meanwhile, the US continued to top the list for the firm’s geographic exposure at 65.5% of the total portfolio, up slightly month-on-month from 65.1%, while the group had increased its exposure to the UK to 14.9% from 11.5%. The firm also added a 0.3% exposure to the French market.